[1]
|
Kosik, K.S. (1993) The Molecular and Cellular Biology of Tau. Brain Pathology, 3, 39-43.
https://doi.org/10.1111/j.1750-3639.1993.tb00724.x
|
[2]
|
Marx, J. (2007) A New Take on Tau. Science, 316, 1416-1417. https://doi.org/10.1126/science.316.5830.1416
|
[3]
|
Andorfer, C., Kress, Y., Espinoza, M., et al. (2003) Hyperphosphorylation and Aggregation of Tau in Mice Expressing Normal Human Tau Isoforms. Journal of Neurochemistry, 86, 582-590.
https://doi.org/10.1046/j.1471-4159.2003.01879.x
|
[4]
|
吴琪. Alzheimer病神经元纤维缠结tau蛋白研究[J]. 中国神经精神疾病杂志, 2000, 26(1): 63-64.
|
[5]
|
马云峰, 王湘庆, 郎森阳. 微管相关蛋白tau蛋白及tau病的研究进展[J]. 解放军医学院学报, 2015, 36(6): 621- 624.
|
[6]
|
Amniai, L., Barbier, P., Sillen, A., et al. (2009) Alzheimer Disease Specific Phosphoepitopes of Tau Interfere with Assembly of Tubulin but Not Binding to Microtubules. The FASEB Journal, 23, 1146-1152.
https://doi.org/10.1096/fj.08-121590
|
[7]
|
Avila, J. (2008) Tau Kinases and Phosphatases. Journal of Cellular and Molecular Medicine, 12, 258-259.
https://doi.org/10.1111/j.1582-4934.2007.00214.x
|
[8]
|
Hanger, D.P., Anderton, B.H. and Noble, W. (2009) Tau Phosphorylation: The Therapeutic Challenge for Neurodegenerative Disease. Trends in Molecular Medicine, 15, 112-119. https://doi.org/10.1016/j.molmed.2009.01.003
|
[9]
|
Liu, F., Li, B., Tung, E.J., et al. (2007) Site-Specific Effects of Tau Phosphorylation on Its Microtubule Assembly Activity and Self-Aggregation. European Journal of Neuroscience, 26, 3429-3436.
https://doi.org/10.1111/j.1460-9568.2007.05955.x
|
[10]
|
Rankin, C.A., Sun, Q. and Gamblin, T.C. (2005) Pseu-do-Phosphorylation of Tau at Ser202 and Thr205 Affects Tau Filament Formation. Molecular Brain Research, 138, 84-93.
|
[11]
|
Mondragón-Rodríguez, S., Basurto-Islas, G., Santa-Maria, I., et al. (2008) Cleavage and Conformational Changes of Tau Protein Follow Phosphorylation during Alzheimer’s Disease. International Journal of Experimental Pathology, 89, 81-90. https://doi.org/10.1111/j.1365-2613.2007.00568.x
|
[12]
|
Mondragón-Rodríguez, S., Basurto-Islas, G., Lee, H., et al. (2010) Causes versus Effects: The Increasing Complexities of Alzheimer’s Disease Pathogenesis. Expert Review of Neurotherapeutics, 10, 683-691.
https://doi.org/10.1586/ern.10.27
|
[13]
|
Mondragón-Rodríguez, S., Mena, R., Binder, L.I., et al. (2008) Conformational Changes and Cleavage of Tau in Pick Bodies Parallel the Early Processing of Tau Found in Alzheimer Pathology. Neuropathology and Applied Neurobiology, 34, 62-75.
|
[14]
|
Medeiros, R., Baglietto-Vargas, D. and Laferla, F.M. (2011) The Role of Tau in Alzheimer’s Disease and Disorders. CNS Neuroscience & Therapeutics, 17, 514-524. https://doi.org/10.1111/j.1755-5949.2010.00177.x
|
[15]
|
Diniz, B.S., Pinto-Janior, J.A. and Forlenza, O.V. (2008) Do CSF Total Tau, Phosphorylated Tau and β-Amyloid 42 Help to Predict Progression of Mild Cognitive Impairment to Alzheimer’s Disease? A Systematic Review and Meta- Analysis of the Literature. The World Journal of Biological Psychiatry, 9, 172-182.
https://doi.org/10.1080/15622970701535502
|
[16]
|
Ewers, M., Buerger, K., Teipel, S.J., et al. (2007) Multicenter Assessment of CSF-Phosphorylated Tau for the Prediction of Conversion of MCI. Neurology, 69, 2205-2212. https://doi.org/10.1212/01.wnl.0000286944.22262.ff
|
[17]
|
Gong, C.X., Liu, F., Grundke-Iqbal, I., et al. (2006) Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer’s Disease: A Therapeutic Target. BioMed Research International, No. 3, Article ID: 31825.
|
[18]
|
Hemandez, P., Lee, G., Sjoberg, M., et al. (2009) Tau Phosphorylation by cdk5 and Fyn in Response to Amyloid Peptide Aβ25-35: Involvement of Lipid Rafts. Journal of Alzheimer’s Disease, 16, 149-156.
https://doi.org/10.3233/JAD-2009-0933
|
[19]
|
Cuehillo-Ibanez, I., Seereeram, A., Byers, H.L., et al. (2008) Phosphorylation of Tau Regulates Its Axonal Transport by Controlling Its Binding to Kinesin. The FASEB Journal, 22, 3186-3195. https://doi.org/10.1096/fj.08-109181
|
[20]
|
Lee, S., Hall, G.F., Shea, T.B., et al. (2011) Potentiation of Tau Aggregation by cdk5 and GSK3β. Journal of Alzheimer’s Disease, 26, 355-364.
|
[21]
|
Wang, H., Zhao, H., Ye, Y., et al. (2010) Focal Cerebral Ischemia Induces Alzheimer’s Disease-Like Pathological Change in Rats. Journal of Huazhong University of Science and Technology (Medical Sciences), 30, 29-36.
https://doi.org/10.1007/s11596-010-0106-4
|
[22]
|
Park, H., Kam, T.I., Kim, Y., et al. (2012) Neuropathogenic Role of Adenylate Kinase-1 in Aβ-Mediated Tau Phosphorylation via AMPK and GSK3β. Human Molecular Genetics, 21, 2725-2737. https://doi.org/10.1093/hmg/dds100
|
[23]
|
Jicha, G.A., Weaver, C., Lane, E., et al. (1999) cAMP-Dependent Protein Kinase Phosphorylations on Tau in Alzheimer’s Disease. The Journal of Neuroscience, 19, 7486-7494.
|
[24]
|
Liu, F., Iqbal, K., Grundke-Iqbal, I., et al. (2004) O-GlcNAcylation Regulates Phosphorylation of Tau: A Mechanism Involved in Alzheimer’s Disease. Proceedings of the National Academy of Sciences of the United States of America, 101, 10804-10809. https://doi.org/10.1073/pnas.0400348101
|
[25]
|
Lefebvre, T., Ferreira, S., Dupont-Wallois, L., et al. (2003) Evidence of a Balance between Phosphorylation and O-GlcNAc Glycosylation of Tau Proteins—A Role in Nuclear Localization. Biochimica et Biophysica Acta, 1619, 167-176.
|
[26]
|
Tian, Q. and Wang, J.Z. (2002) Role of Protein Phosphatases on Alzheimer Disease. Neurosignals, 11, 262-269.
https://doi.org/10.1159/000067425
|
[27]
|
Zhang, C.E., Tian, Q., Wei, W., et al. (2008) Homoeysteine Induces Tau Phosphorylation by Inactivating Protein Phosphatase 2A in Rat Hippocampus. Neurobiology of Aging, 29, 1654-1665.
https://doi.org/10.1016/j.neurobiolaging.2007.04.015
|
[28]
|
Liu, R. and Wang, J.Z. (2009) Protein Phosphatase 2A in Alzheimer’s Disease. Pathophysiology, 16, 273-277.
https://doi.org/10.1016/j.pathophys.2009.02.008
|
[29]
|
Bennecib, M., Gong, C.X., Grundke-Iqbal, I., et al. (2001) Inhibition of PP-2A Up-Regulates CaMII in Rat Forebrain and Induces Hyperphosphorylation of Tau at Ser262/356. FEBS Letters, 490, 15-22.
https://doi.org/10.1016/S0014-5793(01)02127-5
|
[30]
|
Li, L., Sengupta, A., Haque, N., et al. (2004) Memantine Inhibits and Reverses the Alzheimer Type Abnormal Hyperphosphorylation of Tau and Associated Neurodegeneration. FEBS Letters, 566, 261-269.
https://doi.org/10.1016/j.febslet.2004.04.047
|
[31]
|
Iqbal, K. and Grundke-Iqbal, I. (2005) Pharmacological Approaches of Neurofibrillary Degeneration. Current Alzheimer Research, 2, 335-341. https://doi.org/10.2174/1567205054367810
|
[32]
|
Mondragón-Rodríguez, S., Trillaud-Doppia, E., Dudilot, A., et al. (2012) Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-D-Aspartate Receptor-Dependent Tau Phosphorylation. Journal of Biological Chemistry, 287, 32040-32053. https://doi.org/10.1074/jbc.M112.401240
|
[33]
|
Xu, S.H., Brunden, K.R., Trojanowski, J.Q., et al. (2010) Characterization of Tau Fibrillization in Vitro. Alzheimer’s & Dementia, 6, 110-117. https://doi.org/10.1016/j.jalz.2009.06.002
|
[34]
|
Martina, L., Latypovaa, X. and Terroa, F. (2011) Post-Translational Modifications of Tau Protein: Implication for Alzheimer’s Disease. Neurochemistry International, 58, 458-471.
|
[35]
|
Spires-Jones, T.L., Kopeikina, K.J., Koffie, R.M., et al. (2011) Are Tangles as Toxic as They Look? Journal of Molecular Neuroscience, 45, 438-444. https://doi.org/10.1007/s12031-011-9566-7
|